Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: CELLSIGHT TECHNOLOGIES, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-09-16 to 2026-09-15
Current total value of award: $1995174
Description: SBIR PHASE II - TOPIC 396 - IMAGING FOR CANCER IMMUNOTHERAPIES